FBIO
Price
$1.85
Change
-$0.11 (-5.61%)
Updated
Jun 13 closing price
Capitalization
54.7M
PGEN
Price
$1.52
Change
-$0.00 (-0.00%)
Updated
Jun 13 closing price
Capitalization
448.67M
57 days until earnings call
Interact to see
Advertisement

FBIO vs PGEN

Header iconFBIO vs PGEN Comparison
Open Charts FBIO vs PGENBanner chart's image
Fortress Biotech
Price$1.85
Change-$0.11 (-5.61%)
Volume$242.61K
Capitalization54.7M
Precigen
Price$1.52
Change-$0.00 (-0.00%)
Volume$1.25M
Capitalization448.67M
FBIO vs PGEN Comparison Chart
Loading...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBIO vs. PGEN commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIO is a Hold and PGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (FBIO: $1.85 vs. PGEN: $1.52)
Brand notoriety: FBIO and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIO: 129% vs. PGEN: 82%
Market capitalization -- FBIO: $54.7M vs. PGEN: $448.67M
FBIO [@Biotechnology] is valued at $54.7M. PGEN’s [@Biotechnology] market capitalization is $448.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIO’s FA Score shows that 0 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • FBIO’s FA Score: 0 green, 5 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIO is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIO’s TA Score shows that 2 TA indicator(s) are bullish while PGEN’s TA Score has 6 bullish TA indicator(s).

  • FBIO’s TA Score: 2 bullish, 6 bearish.
  • PGEN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than FBIO.

Price Growth

FBIO (@Biotechnology) experienced а -7.50% price change this week, while PGEN (@Biotechnology) price change was +1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

FBIO is expected to report earnings on Mar 31, 2025.

PGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($449M) has a higher market cap than FBIO($54.7M). PGEN YTD gains are higher at: 35.714 vs. FBIO (-8.642). FBIO has higher annual earnings (EBITDA): -108.52M vs. PGEN (-136.11M). FBIO has more cash in the bank: 58.9M vs. PGEN (28.6M). PGEN has less debt than FBIO: PGEN (5.75M) vs FBIO (71.5M). FBIO has higher revenues than PGEN: FBIO (62.5M) vs PGEN (3.96M).
FBIOPGENFBIO / PGEN
Capitalization54.7M449M12%
EBITDA-108.52M-136.11M80%
Gain YTD-8.64235.714-24%
P/E RatioN/AN/A-
Revenue62.5M3.96M1,577%
Total Cash58.9M28.6M206%
Total Debt71.5M5.75M1,244%
FUNDAMENTALS RATINGS
FBIO vs PGEN: Fundamental Ratings
FBIO
PGEN
OUTLOOK RATING
1..100
3242
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4939
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (34) in the Biotechnology industry is somewhat better than the same rating for PGEN (71) in the null industry. This means that FBIO’s stock grew somewhat faster than PGEN’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that FBIO’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's SMR Rating (96) in the null industry is in the same range as FBIO (98) in the Biotechnology industry. This means that PGEN’s stock grew similarly to FBIO’s over the last 12 months.

PGEN's Price Growth Rating (39) in the null industry is in the same range as FBIO (49) in the Biotechnology industry. This means that PGEN’s stock grew similarly to FBIO’s over the last 12 months.

PGEN's P/E Growth Rating (100) in the null industry is in the same range as FBIO (100) in the Biotechnology industry. This means that PGEN’s stock grew similarly to FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPGEN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTOS41.760.52
+1.26%
Kratos Defense & Security Solutions
NHTC4.61-0.09
-1.91%
Natural Health Trends Corp
ARCB68.10-1.89
-2.70%
ArcBest Corp
DELL109.56-3.84
-3.39%
Dell Technologies
IBEX27.89-2.14
-7.13%
IBEX Limited

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-5.61%
AXON - FBIO
38%
Loosely correlated
+0.70%
CRBP - FBIO
38%
Loosely correlated
-3.71%
ABOS - FBIO
35%
Loosely correlated
-6.14%
HOWL - FBIO
35%
Loosely correlated
-5.43%
EYPT - FBIO
34%
Loosely correlated
+1.92%
More

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with PRME. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
N/A
PRME - PGEN
47%
Loosely correlated
N/A
ARCT - PGEN
46%
Loosely correlated
-2.06%
CRSP - PGEN
46%
Loosely correlated
+0.19%
ALEC - PGEN
45%
Loosely correlated
-4.94%
TRDA - PGEN
45%
Loosely correlated
-3.31%
More